CAS RN: 1823331-15-2
2-bromo-5H,6H,7H-pyrrolo[2,3-b]pyrazin-6-one
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20251203
100mg / 250mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1823331-15-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
>97%
0
Out of Stock
Beijing
Inquiry
1823331-15-2 / 2-bromo-5,7-dihydropyrrolo[2,3-b]pyrazin-6-one
Standard CAS: 1823331-15-2
Multi CAS: No
Basic Information
copy
CAS
1823331-15-2 copy
Multi CAS
No copy
Molecular Formula
C6H4BrN3O copy
Molecular Weight
214.020000 copy
Exact Mass
212.953770 copy
SMILES
C1C2=NC(=CN=C2NC1=O)Br copy
InChI
InChI=1S/C6H4BrN3O/c7-4-2-8-6-3(9-4)1-5(11)10-6/h2H,1H2,(H,8,10,11) copy
InChIKey
REECXIWIQIVWRP-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
11 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.17 copy
H-bond acceptors
3 copy
H-bond donors
1 copy
Molar refractivity
42.07 copy
TPSA
54.88 copy
LogP / Solubility
WLOGP
0.73 copy
MLOGP
0.65 copy
Consensus LogP
0.46 copy
Log S (ESOL)
-2.03 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-1.84 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.66 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.5 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy